Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-12-23 Purchase |
2024-12-26 4:01 pm |
Marker Therapeutics Inc. | MRKR | ELMS STEVE Director |
11,085 | $3.2 | $35,472 | 328,338 (Indirect Direct) |
View |
| 2024-03-18 Sale |
2024-03-19 9:48 pm |
ADMA BIOLOGICS INC. | ADMA | ELMS STEVE Director |
461,716 | $6.0724 | $2,803,741 | 2,192,112 (Indirect Direct) |
View |
| 2024-03-13 Sale |
2024-03-15 9:00 pm |
ADMA BIOLOGICS INC. | ADMA | ELMS STEVE Director |
1,038,284 | $6.1057 | $6,339,418 | 2,653,828 (Indirect Direct) |
View |
| 2021-06-29 Purchase |
2021-07-01 6:29 pm |
Elevation Oncology Inc. | ELEV | Aisling Capital IV LP Aisling Capital Partners IV LLC Aisling Capital Partners IV LP ELMS STEVE SCHIFF ANDREW N 10% Owner |
187,500 | $16 | $3,000,000 | 2,834,910 (Direct) |
View |
| 2021-03-16 Purchase |
2021-03-18 4:35 pm |
Marker Therapeutics Inc. | MRKR | ELMS STEVE Director |
1,142,857 | $1.75 | $2,000,000 | 3,159,879 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-19 Option Award |
2025-02-21 9:05 pm |
N/A 2035-02-19 |
ADMA BIOLOGICS INC. | ADMA | ELMS STEVE Director |
27,168 | $0 | 2,228,280 (Direct) |
View |
| 2025-02-12 Option Award |
2025-02-14 5:20 pm |
N/A 2035-02-12 |
Marker Therapeutics Inc. | MRKR | ELMS STEVE Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2024-11-27 Exercise |
2024-12-02 9:02 pm |
N/A 2025-01-30 |
ADMA BIOLOGICS INC. | ADMA | ELMS STEVE Director |
9,000 | $0 | 2,201,112 (Direct) |
View |
| 2024-11-27 Exercise |
2024-12-02 9:02 pm |
N/A N/A |
ADMA BIOLOGICS INC. | ADMA | ELMS STEVE Director |
9,000 | $10.8 | 2,201,112 (Indirect) |
View |
| 2024-06-13 Option Award |
2024-06-17 4:26 pm |
N/A 2034-06-12 |
Elevation Oncology Inc. | ELEV | ELMS STEVE Director |
35,000 | $0 | 35,000 (Indirect) |
View |
| 2024-02-26 Option Award |
2024-02-28 9:00 pm |
N/A 2034-03-26 |
ADMA BIOLOGICS INC. | ADMA | ELMS STEVE Director |
61,581 | $0 | 3,729,653 (Direct) |
View |
| 2023-06-16 Option Award |
2023-06-21 4:09 pm |
N/A 2033-06-15 |
Elevation Oncology Inc. | ELEV | Aisling Capital IV LP Aisling Capital Partners IV LLC Aisling Capital Partners IV LP ELMS STEVE SCHIFF ANDREW N 10% Owner |
31,238 | $0 | 31,238 (Indirect) |
View |
| 2023-06-06 Option Award |
2023-06-08 9:32 pm |
N/A 2033-06-05 |
Marker Therapeutics Inc. | MRKR | ELMS STEVE Director |
8,000 | $0 | 8,000 (Direct) |
View |
| 2023-03-06 Option Award |
2023-03-08 9:30 pm |
N/A 2033-03-06 |
ADMA BIOLOGICS INC. | ADMA | ELMS STEVE Director |
77,445 | $0 | 3,719,702 (Direct) |
View |
| 2022-06-17 Option Award |
2022-06-22 6:43 pm |
N/A 2032-06-16 |
Elevation Oncology Inc. | ELEV | Aisling Capital IV LP Aisling Capital Partners IV LLC Aisling Capital Partners IV LP ELMS STEVE SCHIFF ANDREW N 10% Owner |
15,619 | $0 | 15,619 (Indirect) |
View |
| 2022-05-24 Option Award |
2022-05-26 4:09 pm |
N/A 2032-05-23 |
Marker Therapeutics Inc. | MRKR | ELMS STEVE Director |
80,000 | $0 | 80,000 (Direct) |
View |
| 2022-03-07 Option Award |
2022-03-09 5:59 pm |
N/A 2032-03-07 |
ADMA BIOLOGICS INC. | ADMA | ELMS STEVE Director |
79,758 | $0 | 3,695,429 (Direct) |
View |
| 2021-06-29 Conversion |
2021-07-01 6:29 pm |
N/A N/A |
Elevation Oncology Inc. | ELEV | Aisling Capital IV LP Aisling Capital Partners IV LLC Aisling Capital Partners IV LP ELMS STEVE SCHIFF ANDREW N 10% Owner |
12,288,426 | $0 | 2,834,910 (Direct) |
View |
| 2021-06-24 Option Award |
2021-06-28 6:18 pm |
N/A 2031-06-23 |
Elevation Oncology Inc. | ELEV | Aisling Capital IV LP Aisling Capital Partners IV LLC Aisling Capital Partners IV LP ELMS STEVE SCHIFF ANDREW N 10% Owner |
31,238 | $0 | 31,238 (Indirect) |
View |
Ownership |
2021-06-24 6:32 pm |
N/A N/A |
Elevation Oncology Inc. | ELEV | Aisling Capital IV LP ELMS STEVE Aisling Capital Partners IV LLC Aisling Capital Partners IV LP SCHIFF ANDREW N 10% Owner |
0 | $0 | 2,647,410 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-14 8:38 pm |
N/A 2031-06-09 |
Zosano Pharma Corp | ZSAN | ELMS STEVE Director |
45,000 | $0 | 2,770,726 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-10 6:55 pm |
N/A N/A |
Marker Therapeutics Inc. | MRKR | ELMS STEVE Director |
12,658 | $0 | 3,172,537 (Direct) |
View |
| 2021-02-25 Option Award |
2021-03-01 9:02 pm |
N/A 2031-02-25 |
ADMA BIOLOGICS INC. | ADMA | ELMS STEVE Director |
55,000 | $0 | 55,000 (Direct) |
View |
| 2020-05-19 Ownership |
2021-02-12 5:12 pm |
N/A N/A |
Marker Therapeutics Inc. | MRKR | ELMS STEVE Director |
17,022 | $0 | 2,017,022 (Direct) |
View |
Ownership |
2021-02-12 5:12 pm |
N/A N/A |
Marker Therapeutics Inc. | MRKR | ELMS STEVE Director |
0 | $0 | 2,017,022 (Indirect) |
View |
| 2020-06-25 Option Award |
2020-06-29 9:47 pm |
N/A N/A |
Zosano Pharma Corp | ZSAN | ELMS STEVE Director |
7,500 | $0 | 2,725,766 (Direct) |
View |
| 2020-06-03 Option Award |
2020-06-05 5:10 pm |
N/A 2030-06-02 |
Zosano Pharma Corp | ZSAN | ELMS STEVE Director |
15,000 | $0 | 15,000 (Direct) |
View |